The growing adoption of screening technologies such as nucleic acid amplification test, Western Blotting, Enzyme-Linked Immunosorbent Assay, and PCR-RNA is boosting the growth of the blood screening market during the forecast period. Rising implementation of NAT (Nucleic Acid Testing) with a positive impact to adopt cutting edge technologies in transfusion services across the globe is flourishing the growth of the market. In the early stage, NAT PCR (polymerase chain reaction) testing aids infection in donated blood that enhanced the value of blood safety. Moreover, voluntary donors have been found that have a lower incidence of TTI (Transfusion Transmitted Infections) as compared to replacement donors.



Get Free Sample Copy @

https://www.omrglobal.com/request-sample/blood-screening-market


In September 2019, the prevalence of Hepatitis B is 4%, Hepatitis C is 1% and HIV is 0.26% in India and around 70% of HIV infected individual is aware regarding early detection. The introduction of NAT is considerable reduce many such infections and TTIs associated mortality. NAT directly detects the RNA & DNA of the virus named as HIV and Hepatitis C and B. It is the most sensitive technique for detection of the infectious blood screening test. It is an essential requirement for voluntary blood donor and growing adoption of better screening standards that include NAT PCR on the World Blood Donor Day.



Browse for Full Report at:

https://www.omrglobal.com/industry-reports/blood-screening-market


The test of Enzyme-Linked Immunosorbent Assay test (ELISA) is commonly utilized for the laboratory to detect antibodies in the blood for the screening test. ELISA used to screen for HIV infection due to its relatively simple methodology, suitability for testing a significant number of blood samples in blood testing centers and inherent large sensitivity. Approximately more than 40 different ELISA test kits are available and about 10 are licensed by the FDA (Food and Drug Administration) for utilization in the US. The ELISA test and Western blotting test is the blood antibody test which is used to detect HIV. Thus, due to the adoption of these techniques is boosting the growth of the blood screening market during the forecast period.

Blood screening for HIV, HCV, and HBV through serological tests for HBsAg to HIV and HCV is mandatory in India. The seronon blood donation is at risk of transferring of TTIs and due to this need for sensitive screening test occur to reduce the residual risk that has been decreased considerably in the country where NAT has been implemented. The awareness among people regarding NAT PCR is rising in India. Furthermore, in September 2019, around 9% donated blood get screened through NAT and currently NAT is not mandatory in India for the screening of TTIs.



Global Blood Screening Market Segmentation

By Screening Technology
Nucleic Acid Amplification Test
Western Blotting
Enzyme-Linked Immunosorbent Assay
PCR-RNA


By Products
Testing Instruments
Reagents


By End-Users
Blood Banks
Hospitals
Laboratories


Global Blood Screening Market – Segment by Region

North America
US
Canada


Europe
Germany
UK
France
Spain
Italy
Rest of Europe


Asia-Pacific
China
Japan
India
Rest of Asia-Pacific


Rest of the World
Middle East & Africa
Latin America


For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/blood-screening-market



About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404